Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL728510 | 0.84 | MEN1 (0.60) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL7129845 | 0.82 | L3MBTL1 (0.53) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL4732623 | 0.80 | MAPT (0.62) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL8855198 | 0.78 | MEN1 (0.56) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL11577264 | 0.77 | PABPC1 (0.49) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL9765744 | 0.77 | MAPT (0.58) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL9393651 | 0.77 | MAPT (0.67) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL27680308 | 0.75 | MAPT (0.46) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL5696019 | 0.74 | MAPT (0.54) | MEN1KMT2APABPC1L3MBTL1MAPT | |
| SCHEMBL11316550 | 0.74 | MAPT (0.62) | MEN1KMT2APABPC1L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4230619-A | — | — | None | — | — | JP | disclosed |
| US-20030130272-A1 | Anthracene derivatives as anti-cancer agents | BTG INTERNATIONAL LIMITED (GB) | 2003-07-10 | — | — | US | disclosed |
| EP-1244624-A1 | ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS | BTG INTERNATIONAL LIMITED (GB) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001044190-A1 | ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS | BTG INTERNATIONAL LIMITED (GB) | 2001-06-21 | — | — | WO | disclosed |
| JP-H04230619-A | HAIR DYEING COMPOSITION CONTAINING ANTHRAQUINONE COMPOUND | L'OREAL SA | 1992-08-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130272-A1 | Anthracene derivatives as anti-cancer agents | TOP2B, TOP1, TOP2A | MEN1 3649/4885KMT2A 3784/4885PABPC1 2753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.